Next 10 S&P 500 Stocks That Rose In The Crisis: It’s A Market Of Stocks: Part 2



In part 1 of this 3 part series I provided a quick cursory look at 10 of 30 stocks that MarketWatch pointed out have done very well in spite of the coronavirus market crash.  In that first group of 10, there were several names that were reasonably valued.  However, in this second group you will see most of them being significantly overvalued.  The one exception would be Vertex Pharmaceuticals, a company that is currently experiencing a strong growth spurt.  Finally, not recommending any stocks – this is a cursory look only to illustrate how different stocks are even in this horrible state we find ourselves in today.

FAST Graphs Analyze Out Lout Reviewing Eli Lilly (LLY), Old Dominion Freight (ODFL), Citrix Systems (CTXS), Hormel Foods (HRL), Activision (ATVI), Clorox (CLX), Microsoft (MSFT), Newmont (NEM), Henry Jack (JKHY), Vertex (VRTX)

Disclosure:  No Positions

Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment advisor as to the suitability of such investments for his specific situation.

Unlock data on thousands of companies

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.